<?xml version="1.0"?>
<rss xmlns:dc="http://purl.org/dc/elements/1.1/" version="2.0" xml:base="https://research.bidmc.org/rss.xml"><channel><title/><link>https://research.bidmc.org/rss.xml</link><description>Openscholar RSS Feeds will show latest apps, publications and terms on the site.</description><language>en</language><item><title>Long COVID involves activation of proinflammatory and immune exhaustion pathways.</title><link>https://research.bidmc.org/ai-ris-collier/publications/long-covid-involves-activation-proinflammatory-and-immune-exhaustion-pathways</link><dc:creator>amichae1</dc:creator><pubdate>Tuesday, December 16, 2025, 11:07am</pubdate><guid>24042 at https://research.bidmc.org</guid></item><item><title>Immunogenicity of JN.1 and KP.2 COVID-19 mRNA vaccines against emerging SARS-CoV-2 variants.</title><link>https://research.bidmc.org/ai-ris-collier/publications/immunogenicity-jn1-and-kp2-covid-19-mrna-vaccines-against-emerging-sars-cov-2-variants</link><dc:creator>amichae1</dc:creator><pubdate>Tuesday, December 16, 2025, 11:07am</pubdate><guid>24043 at https://research.bidmc.org</guid></item><item><title>Utility of the US Preventive Services Task Force for Preeclampsia Risk Assessment and Aspirin Prophylaxis.</title><link>https://research.bidmc.org/ai-ris-collier/publications/utility-us-preventive-services-task-force-preeclampsia-risk-assessment-and-aspirin</link><dc:creator>amichae1</dc:creator><pubdate>Tuesday, December 16, 2025, 11:07am</pubdate><guid>24044 at https://research.bidmc.org</guid></item><item><title>Investigation of maternal outcomes following respiratory syncytial virus vaccination in the third trimester: insights from a real-world United States electronic health records database.</title><link>https://research.bidmc.org/ai-ris-collier/publications/investigation-maternal-outcomes-following-respiratory-syncytial-virus-vaccination</link><dc:creator>amichae1</dc:creator><pubdate>Tuesday, December 16, 2025, 11:07am</pubdate><guid>24045 at https://research.bidmc.org</guid></item><item><title>Molecular subtyping of hypertensive disorders of pregnancy.</title><link>https://research.bidmc.org/ai-ris-collier/publications/molecular-subtyping-hypertensive-disorders-pregnancy</link><dc:creator>amichae1</dc:creator><pubdate>Tuesday, December 16, 2025, 11:07am</pubdate><guid>24046 at https://research.bidmc.org</guid></item><item><title>Maternal RSVpreF and Infant Nirsevimab Immunizations Uptake During Respiratory Syncytial Virus Season.</title><link>https://research.bidmc.org/ai-ris-collier/publications/maternal-rsvpref-and-infant-nirsevimab-immunizations-uptake-during-respiratory</link><dc:creator>amichae1</dc:creator><pubdate>Tuesday, December 16, 2025, 11:07am</pubdate><guid>24047 at https://research.bidmc.org</guid></item><item><title>A Day in the Woods in Pregnancy: Fetal and Neonatal Implications.</title><link>https://research.bidmc.org/ai-ris-collier/publications/day-woods-pregnancy-fetal-and-neonatal-implications</link><dc:creator>amichae1</dc:creator><pubdate>Tuesday, December 16, 2025, 11:07am</pubdate><guid>24048 at https://research.bidmc.org</guid></item><item><title>SARS-CoV-2 XBB.1.5 mRNA booster vaccination elicits limited mucosal immunity.</title><link>https://research.bidmc.org/ai-ris-collier/publications/sars-cov-2-xbb15-mrna-booster-vaccination-elicits-limited-mucosal-immunity</link><dc:creator>amichae1</dc:creator><pubdate>Tuesday, December 16, 2025, 11:07am</pubdate><guid>24049 at https://research.bidmc.org</guid></item><item><title>Decline of Mpox Antibody Responses After Modified Vaccinia Ankara-Bavarian Nordic Vaccination.</title><link>https://research.bidmc.org/ai-ris-collier/publications/decline-mpox-antibody-responses-after-modified-vaccinia-ankara-bavarian-nordic</link><dc:creator>amichae1</dc:creator><pubdate>Tuesday, December 16, 2025, 11:07am</pubdate><guid>24050 at https://research.bidmc.org</guid></item><item><title>Rapid Decline of Mpox Antibody Responses Following MVA-BN Vaccination.</title><link>https://research.bidmc.org/ai-ris-collier/publications/rapid-decline-mpox-antibody-responses-following-mva-bn-vaccination</link><dc:creator>amichae1</dc:creator><pubdate>Tuesday, December 16, 2025, 11:07am</pubdate><guid>24051 at https://research.bidmc.org</guid></item><item><title>Insights from an observational translational research program during the COVID-19 pandemic: Four years of experience.</title><link>https://research.bidmc.org/ai-ris-collier/publications/insights-observational-translational-research-program-during-covid-19-pandemic-four</link><dc:creator>amichae1</dc:creator><pubdate>Tuesday, December 16, 2025, 11:07am</pubdate><guid>24052 at https://research.bidmc.org</guid></item><item><title>High Frequency of Prior Severe Acute Respiratory Syndrome Coronavirus 2 Infection by Sensitive Nucleocapsid Assays.</title><link>https://research.bidmc.org/ai-ris-collier/publications/high-frequency-prior-severe-acute-respiratory-syndrome-coronavirus-2-infection</link><dc:creator>amichae1</dc:creator><pubdate>Tuesday, December 16, 2025, 11:07am</pubdate><guid>24053 at https://research.bidmc.org</guid></item><item><title>Neutralization of SARS-CoV-2 Omicron subvariant BA.2.87.1.</title><link>https://research.bidmc.org/ai-ris-collier/publications/neutralization-sars-cov-2-omicron-subvariant-ba2871</link><dc:creator>amichae1</dc:creator><pubdate>Tuesday, December 16, 2025, 11:07am</pubdate><guid>24054 at https://research.bidmc.org</guid></item><item><title>Waning immunity and IgG4 responses following bivalent mRNA boosting.</title><link>https://research.bidmc.org/ai-ris-collier/publications/waning-immunity-and-igg4-responses-following-bivalent-mrna-boosting</link><dc:creator>amichae1</dc:creator><pubdate>Tuesday, December 16, 2025, 11:07am</pubdate><guid>24055 at https://research.bidmc.org</guid></item><item><title>Activation of coagulation and proinflammatory pathways in thrombosis with thrombocytopenia syndrome and following COVID-19 vaccination.</title><link>https://research.bidmc.org/ai-ris-collier/publications/activation-coagulation-and-proinflammatory-pathways-thrombosis-thrombocytopenia</link><dc:creator>amichae1</dc:creator><pubdate>Tuesday, December 16, 2025, 11:07am</pubdate><guid>24056 at https://research.bidmc.org</guid></item><item><title>Neutralization escape by SARS-CoV-2 Omicron subvariant BA.2.86.</title><link>https://research.bidmc.org/ai-ris-collier/publications/neutralization-escape-sars-cov-2-omicron-subvariant-ba286</link><dc:creator>amichae1</dc:creator><pubdate>Tuesday, December 16, 2025, 11:07am</pubdate><guid>24057 at https://research.bidmc.org</guid></item><item><title>Contrasting Effects of SARS-CoV-2 Vaccination vs. Infection on Antibody and TCR Repertoires.</title><link>https://research.bidmc.org/ai-ris-collier/publications/contrasting-effects-sars-cov-2-vaccination-vs-infection-antibody-and-tcr-repertoires</link><dc:creator>amichae1</dc:creator><pubdate>Tuesday, December 16, 2025, 11:07am</pubdate><guid>24058 at https://research.bidmc.org</guid></item><item><title>Resilience as a potential modifier of racial inequities in preterm birth.</title><link>https://research.bidmc.org/ai-ris-collier/publications/resilience-potential-modifier-racial-inequities-preterm-birth</link><dc:creator>amichae1</dc:creator><pubdate>Tuesday, December 16, 2025, 11:07am</pubdate><guid>24059 at https://research.bidmc.org</guid></item><item><title>Selective SARS-CoV2 BA.2 escape of antibody Fc/Fc-receptor interactions.</title><link>https://research.bidmc.org/ai-ris-collier/publications/selective-sars-cov2-ba2-escape-antibody-fcfc-receptor-interactions</link><dc:creator>amichae1</dc:creator><pubdate>Tuesday, December 16, 2025, 11:07am</pubdate><guid>24060 at https://research.bidmc.org</guid></item><item><title>COVID-19 Therapeutics and Considerations for Pregnancy.</title><link>https://research.bidmc.org/ai-ris-collier/publications/covid-19-therapeutics-and-considerations-pregnancy</link><dc:creator>amichae1</dc:creator><pubdate>Tuesday, December 16, 2025, 11:07am</pubdate><guid>24061 at https://research.bidmc.org</guid></item><item><title>Altered Cytokine Production in Human Intervillous Blood T Cells in Preeclampsia.</title><link>https://research.bidmc.org/ai-ris-collier/publications/altered-cytokine-production-human-intervillous-blood-t-cells-preeclampsia</link><dc:creator>amichae1</dc:creator><pubdate>Tuesday, December 16, 2025, 11:07am</pubdate><guid>24062 at https://research.bidmc.org</guid></item><item><title>Waning Immunity Against XBB.1.5 Following Bivalent mRNA Boosters.</title><link>https://research.bidmc.org/ai-ris-collier/publications/waning-immunity-against-xbb15-following-bivalent-mrna-boosters</link><dc:creator>amichae1</dc:creator><pubdate>Tuesday, December 16, 2025, 11:07am</pubdate><guid>24063 at https://research.bidmc.org</guid></item><item><title>Substantial Neutralization Escape by SARS-CoV-2 Omicron Variants BQ.1.1 and XBB.1.</title><link>https://research.bidmc.org/ai-ris-collier/publications/substantial-neutralization-escape-sars-cov-2-omicron-variants-bq11-and-xbb1</link><dc:creator>amichae1</dc:creator><pubdate>Tuesday, December 16, 2025, 11:07am</pubdate><guid>24064 at https://research.bidmc.org</guid></item><item><title>Immunogenicity of BA.5 Bivalent mRNA Vaccine Boosters.</title><link>https://research.bidmc.org/ai-ris-collier/publications/immunogenicity-ba5-bivalent-mrna-vaccine-boosters</link><dc:creator>amichae1</dc:creator><pubdate>Tuesday, December 16, 2025, 11:07am</pubdate><guid>24065 at https://research.bidmc.org</guid></item><item><title>Pan-neutralizing, germline-encoded antibodies against SARS-CoV-2: Addressing the long-term problem of escape variants.</title><link>https://research.bidmc.org/ai-ris-collier/publications/pan-neutralizing-germline-encoded-antibodies-against-sars-cov-2-addressing-long-term</link><dc:creator>amichae1</dc:creator><pubdate>Tuesday, December 16, 2025, 11:07am</pubdate><guid>24066 at https://research.bidmc.org</guid></item><item><title>Immunogenicity of the BA.5 Bivalent mRNA Vaccine Boosters.</title><link>https://research.bidmc.org/ai-ris-collier/publications/immunogenicity-ba5-bivalent-mrna-vaccine-boosters-0</link><dc:creator>amichae1</dc:creator><pubdate>Tuesday, December 16, 2025, 11:07am</pubdate><guid>24067 at https://research.bidmc.org</guid></item><item><title>Cervical microRNA expression and spontaneous preterm birth.</title><link>https://research.bidmc.org/ai-ris-collier/publications/cervical-microrna-expression-and-spontaneous-preterm-birth</link><dc:creator>amichae1</dc:creator><pubdate>Tuesday, December 16, 2025, 11:07am</pubdate><guid>24068 at https://research.bidmc.org</guid></item><item><title>Neutralization Escape by SARS-CoV-2 Omicron Subvariant BA.4.6.</title><link>https://research.bidmc.org/ai-ris-collier/publications/neutralization-escape-sars-cov-2-omicron-subvariant-ba46</link><dc:creator>amichae1</dc:creator><pubdate>Tuesday, December 16, 2025, 11:07am</pubdate><guid>24069 at https://research.bidmc.org</guid></item><item><title>Durability of Heterologous and Homologous COVID-19 Vaccine Boosts.</title><link>https://research.bidmc.org/ai-ris-collier/publications/durability-heterologous-and-homologous-covid-19-vaccine-boosts</link><dc:creator>amichae1</dc:creator><pubdate>Tuesday, December 16, 2025, 11:07am</pubdate><guid>24070 at https://research.bidmc.org</guid></item><item><title>High-Dose Inhaled Nitric Oxide for the Treatment of Spontaneously Breathing Pregnant Patients With Severe Coronavirus Disease 2019 (COVID-19) Pneumonia.</title><link>https://research.bidmc.org/ai-ris-collier/publications/high-dose-inhaled-nitric-oxide-treatment-spontaneously-breathing-pregnant-patients</link><dc:creator>amichae1</dc:creator><pubdate>Tuesday, December 16, 2025, 11:07am</pubdate><guid>24071 at https://research.bidmc.org</guid></item><item><title>Neutralization Escape by SARS-CoV-2 Omicron Subvariants BA.2.12.1, BA.4, and BA.5.</title><link>https://research.bidmc.org/ai-ris-collier/publications/neutralization-escape-sars-cov-2-omicron-subvariants-ba2121-ba4-and-ba5</link><dc:creator>amichae1</dc:creator><pubdate>Tuesday, December 16, 2025, 11:07am</pubdate><guid>24072 at https://research.bidmc.org</guid></item><item><title>mRNA-1273 and BNT162b2 COVID-19 vaccines elicit antibodies with differences in Fc-mediated effector functions.</title><link>https://research.bidmc.org/ai-ris-collier/publications/mrna-1273-and-bnt162b2-covid-19-vaccines-elicit-antibodies-differences-fc-mediated</link><dc:creator>amichae1</dc:creator><pubdate>Tuesday, December 16, 2025, 11:07am</pubdate><guid>24073 at https://research.bidmc.org</guid></item><item><title>Neutralization of the SARS-CoV-2 Omicron BA.1 and BA.2 Variants.</title><link>https://research.bidmc.org/ai-ris-collier/publications/neutralization-sars-cov-2-omicron-ba1-and-ba2-variants</link><dc:creator>amichae1</dc:creator><pubdate>Tuesday, December 16, 2025, 11:07am</pubdate><guid>24074 at https://research.bidmc.org</guid></item><item><title>Characterization of immune responses in fully vaccinated individuals after breakthrough infection with the SARS-CoV-2 delta variant.</title><link>https://research.bidmc.org/ai-ris-collier/publications/characterization-immune-responses-fully-vaccinated-individuals-after-breakthrough</link><dc:creator>amichae1</dc:creator><pubdate>Tuesday, December 16, 2025, 11:07am</pubdate><guid>24075 at https://research.bidmc.org</guid></item><item><title>Comparable Neutralization of the SARS-CoV-2 Omicron BA.1 and BA.2 Variants.</title><link>https://research.bidmc.org/ai-ris-collier/publications/comparable-neutralization-sars-cov-2-omicron-ba1-and-ba2-variants</link><dc:creator>amichae1</dc:creator><pubdate>Tuesday, December 16, 2025, 11:07am</pubdate><guid>24076 at https://research.bidmc.org</guid></item><item><title>Vaccines elicit highly conserved cellular immunity to SARS-CoV-2 Omicron.</title><link>https://research.bidmc.org/ai-ris-collier/publications/vaccines-elicit-highly-conserved-cellular-immunity-sars-cov-2-omicron</link><dc:creator>amichae1</dc:creator><pubdate>Tuesday, December 16, 2025, 11:07am</pubdate><guid>24077 at https://research.bidmc.org</guid></item><item><title>Vaccines Elicit Highly Cross-Reactive Cellular Immunity to the SARS-CoV-2 Omicron Variant.</title><link>https://research.bidmc.org/ai-ris-collier/publications/vaccines-elicit-highly-cross-reactive-cellular-immunity-sars-cov-2-omicron-variant</link><dc:creator>amichae1</dc:creator><pubdate>Tuesday, December 16, 2025, 11:07am</pubdate><guid>24078 at https://research.bidmc.org</guid></item><item><title>Multifoetal gestations mediate the effect of in vitro fertilisation (IVF) on ischaemic placental disease in autologous oocyte IVF more than donor oocyte IVF.</title><link>https://research.bidmc.org/ai-ris-collier/publications/multifoetal-gestations-mediate-effect-vitro-fertilisation-ivf-ischaemic-placental</link><dc:creator>amichae1</dc:creator><pubdate>Tuesday, December 16, 2025, 11:07am</pubdate><guid>24079 at https://research.bidmc.org</guid></item><item><title>Reexamining intrapartum glucose control in patients with diabetes and risk of neonatal hypoglycemia.</title><link>https://research.bidmc.org/ai-ris-collier/publications/reexamining-intrapartum-glucose-control-patients-diabetes-and-risk-neonatal</link><dc:creator>amichae1</dc:creator><pubdate>Tuesday, December 16, 2025, 11:07am</pubdate><guid>24080 at https://research.bidmc.org</guid></item><item><title>Incidence of small-for-gestational-age infant birthweight following early intertwin fetal growth discordance in dichorionic and monochorionic twin pregnancies.</title><link>https://research.bidmc.org/ai-ris-collier/publications/incidence-small-gestational-age-infant-birthweight-following-early-intertwin-fetal</link><dc:creator>amichae1</dc:creator><pubdate>Tuesday, December 16, 2025, 11:07am</pubdate><guid>24081 at https://research.bidmc.org</guid></item><item><title>Coronavirus Disease 2019 Messenger RNA Vaccine Immunogenicity in Immunosuppressed Individuals.</title><link>https://research.bidmc.org/ai-ris-collier/publications/coronavirus-disease-2019-messenger-rna-vaccine-immunogenicity-immunosuppressed</link><dc:creator>amichae1</dc:creator><pubdate>Tuesday, December 16, 2025, 11:07am</pubdate><guid>24082 at https://research.bidmc.org</guid></item><item><title>Selective functional antibody transfer into the breastmilk after SARS-CoV-2 infection.</title><link>https://research.bidmc.org/ai-ris-collier/publications/selective-functional-antibody-transfer-breastmilk-after-sars-cov-2-infection</link><dc:creator>amichae1</dc:creator><pubdate>Tuesday, December 16, 2025, 11:07am</pubdate><guid>24083 at https://research.bidmc.org</guid></item><item><title>Immune Responses in Fully Vaccinated Individuals Following Breakthrough Infection with the SARS-CoV-2 Delta Variant in Provincetown, Massachusetts.</title><link>https://research.bidmc.org/ai-ris-collier/publications/immune-responses-fully-vaccinated-individuals-following-breakthrough-infection-sars</link><dc:creator>amichae1</dc:creator><pubdate>Tuesday, December 16, 2025, 11:07am</pubdate><guid>24084 at https://research.bidmc.org</guid></item><item><title>Differential Kinetics of Immune Responses Elicited by Covid-19 Vaccines.</title><link>https://research.bidmc.org/ai-ris-collier/publications/differential-kinetics-immune-responses-elicited-covid-19-vaccines</link><dc:creator>amichae1</dc:creator><pubdate>Tuesday, December 16, 2025, 11:07am</pubdate><guid>24085 at https://research.bidmc.org</guid></item><item><title>Tie2 activation protects against prothrombotic endothelial dysfunction in COVID-19.</title><link>https://research.bidmc.org/ai-ris-collier/publications/tie2-activation-protects-against-prothrombotic-endothelial-dysfunction-covid-19</link><dc:creator>amichae1</dc:creator><pubdate>Tuesday, December 16, 2025, 11:07am</pubdate><guid>24086 at https://research.bidmc.org</guid></item><item><title>Subtle immunological differences in mRNA-1273 and BNT162b2 COVID-19 vaccine induced Fc-functional profiles.</title><link>https://research.bidmc.org/ai-ris-collier/publications/subtle-immunological-differences-mrna-1273-and-bnt162b2-covid-19-vaccine-induced-fc</link><dc:creator>amichae1</dc:creator><pubdate>Tuesday, December 16, 2025, 11:07am</pubdate><guid>24087 at https://research.bidmc.org</guid></item><item><title>Tie2 activation protects against prothrombotic endothelial dysfunction in COVID-19.</title><link>https://research.bidmc.org/ai-ris-collier/publications/tie2-activation-protects-against-prothrombotic-endothelial-dysfunction-covid-19-0</link><dc:creator>amichae1</dc:creator><pubdate>Tuesday, December 16, 2025, 11:07am</pubdate><guid>24088 at https://research.bidmc.org</guid></item><item><title>Immunogenicity of COVID-19 mRNA Vaccines in Pregnant and Lactating Women.</title><link>https://research.bidmc.org/ai-ris-collier/publications/immunogenicity-covid-19-mrna-vaccines-pregnant-and-lactating-women</link><dc:creator>amichae1</dc:creator><pubdate>Tuesday, December 16, 2025, 11:07am</pubdate><guid>24089 at https://research.bidmc.org</guid></item><item><title>Vertical transmission of SARS-CoV-2: consider the denominator.</title><link>https://research.bidmc.org/ai-ris-collier/publications/vertical-transmission-sars-cov-2-consider-denominator</link><dc:creator>amichae1</dc:creator><pubdate>Tuesday, December 16, 2025, 11:07am</pubdate><guid>24090 at https://research.bidmc.org</guid></item><item><title>Correlates of Neutralization against SARS-CoV-2 Variants of Concern by Early Pandemic Sera.</title><link>https://research.bidmc.org/ai-ris-collier/publications/correlates-neutralization-against-sars-cov-2-variants-concern-early-pandemic-sera</link><dc:creator>amichae1</dc:creator><pubdate>Tuesday, December 16, 2025, 11:07am</pubdate><guid>24091 at https://research.bidmc.org</guid></item><item><title>Review of the immune mechanisms of preeclampsia and the potential of immune modulating therapy.</title><link>https://research.bidmc.org/ai-ris-collier/publications/review-immune-mechanisms-preeclampsia-and-potential-immune-modulating-therapy</link><dc:creator>amichae1</dc:creator><pubdate>Tuesday, December 16, 2025, 11:07am</pubdate><guid>24092 at https://research.bidmc.org</guid></item><item><title>Assessment of Maternal and Neonatal SARS-CoV-2 Viral Load, Transplacental Antibody Transfer, and Placental Pathology in Pregnancies During the COVID-19 Pandemic.</title><link>https://research.bidmc.org/ai-ris-collier/publications/assessment-maternal-and-neonatal-sars-cov-2-viral-load-transplacental-antibody</link><dc:creator>amichae1</dc:creator><pubdate>Tuesday, December 16, 2025, 11:07am</pubdate><guid>24093 at https://research.bidmc.org</guid></item><item><title>Racial and ethnic representation in epigenomic studies of preterm birth: a systematic review.</title><link>https://research.bidmc.org/ai-ris-collier/publications/racial-and-ethnic-representation-epigenomic-studies-preterm-birth-systematic-review</link><dc:creator>amichae1</dc:creator><pubdate>Tuesday, December 16, 2025, 11:07am</pubdate><guid>24094 at https://research.bidmc.org</guid></item><item><title>Compassionate Use of Remdesivir in Pregnant Women With Severe Coronavirus Disease 2019.</title><link>https://research.bidmc.org/ai-ris-collier/publications/compassionate-use-remdesivir-pregnant-women-severe-coronavirus-disease-2019</link><dc:creator>amichae1</dc:creator><pubdate>Tuesday, December 16, 2025, 11:07am</pubdate><guid>24095 at https://research.bidmc.org</guid></item><item><title>A multidisciplinary telemedicine model for management of coronavirus disease 2019 (COVID-19) in obstetrical patients.</title><link>https://research.bidmc.org/ai-ris-collier/publications/multidisciplinary-telemedicine-model-management-coronavirus-disease-2019-covid-19</link><dc:creator>amichae1</dc:creator><pubdate>Tuesday, December 16, 2025, 11:07am</pubdate><guid>24096 at https://research.bidmc.org</guid></item><item><title>Sustained maternal antibody and cellular immune responses in pregnant women infected with Zika virus and mother to infant transfer of Zika-specific antibodies.</title><link>https://research.bidmc.org/ai-ris-collier/publications/sustained-maternal-antibody-and-cellular-immune-responses-pregnant-women-infected-zika</link><dc:creator>amichae1</dc:creator><pubdate>Tuesday, December 16, 2025, 11:07am</pubdate><guid>24097 at https://research.bidmc.org</guid></item><item><title>Maternal Mortality in the United States: Updates on Trends, Causes, and Solutions.</title><link>https://research.bidmc.org/ai-ris-collier/publications/maternal-mortality-united-states-updates-trends-causes-and-solutions</link><dc:creator>amichae1</dc:creator><pubdate>Tuesday, December 16, 2025, 11:07am</pubdate><guid>24098 at https://research.bidmc.org</guid></item><item><title>Who receives a medical evaluation for infertility in the United States?</title><link>https://research.bidmc.org/ai-ris-collier/publications/who-receives-medical-evaluation-infertility-united-states</link><dc:creator>amichae1</dc:creator><pubdate>Tuesday, December 16, 2025, 11:07am</pubdate><guid>24099 at https://research.bidmc.org</guid></item><item><title>Regulated release of nitric oxide by nonhematopoietic stroma controls expansion of the activated T cell pool in lymph nodes.</title><link>https://research.bidmc.org/ai-ris-collier/publications/regulated-release-nitric-oxide-nonhematopoietic-stroma-controls-expansion-activated-t</link><dc:creator>amichae1</dc:creator><pubdate>Tuesday, December 16, 2025, 11:07am</pubdate><guid>24100 at https://research.bidmc.org</guid></item><item><title>Lymph node fibroblastic reticular cells directly present peripheral tissue antigen under steady-state and inflammatory conditions.</title><link>https://research.bidmc.org/ai-ris-collier/publications/lymph-node-fibroblastic-reticular-cells-directly-present-peripheral-tissue-antigen</link><dc:creator>amichae1</dc:creator><pubdate>Tuesday, December 16, 2025, 11:07am</pubdate><guid>24101 at https://research.bidmc.org</guid></item><item><title>Deaf1 isoforms control the expression of genes encoding peripheral tissue antigens in the pancreatic lymph nodes during type 1 diabetes.</title><link>https://research.bidmc.org/ai-ris-collier/publications/deaf1-isoforms-control-expression-genes-encoding-peripheral-tissue-antigens-pancreatic</link><dc:creator>amichae1</dc:creator><pubdate>Tuesday, December 16, 2025, 11:07am</pubdate><guid>24102 at https://research.bidmc.org</guid></item><item><title>Interleukin-15/interleukin-15R alpha complexes promote destruction of established tumors by reviving tumor-resident CD8+ T cells.</title><link>https://research.bidmc.org/ai-ris-collier/publications/interleukin-15interleukin-15r-alpha-complexes-promote-destruction-established-tumors</link><dc:creator>amichae1</dc:creator><pubdate>Tuesday, December 16, 2025, 11:07am</pubdate><guid>24103 at https://research.bidmc.org</guid></item><item><title>Peripheral antigen display by lymph node stroma promotes T cell tolerance to intestinal self.</title><link>https://research.bidmc.org/ai-ris-collier/publications/peripheral-antigen-display-lymph-node-stroma-promotes-t-cell-tolerance-intestinal-self</link><dc:creator>amichae1</dc:creator><pubdate>Tuesday, December 16, 2025, 11:07am</pubdate><guid>24104 at https://research.bidmc.org</guid></item></channel></rss>
